-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E5jkr5RLqErDltIOOik9F9FHlWs1B9hu0CCdz4z2aE1dw+SXPN0YsUWc9kQay/W2 ZqXQw0kF/URvBoCFLEmLAA== 0000921895-08-001447.txt : 20080515 0000921895-08-001447.hdr.sgml : 20080515 20080515162458 ACCESSION NUMBER: 0000921895-08-001447 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080515 DATE AS OF CHANGE: 20080515 EFFECTIVENESS DATE: 20080515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACCIPITER CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001280190 IRS NUMBER: 134220800 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-10741 FILM NUMBER: 08838089 BUSINESS ADDRESS: STREET 1: 399 PARK AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2127058700 MAIL ADDRESS: STREET 1: 399 PARK AVENUE STREET 2: 38TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: ACCIPITER CAPITAL MANAGEMENT DATE OF NAME CHANGE: 20040213 13F-HR 1 form13fhr06588_03312008.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2008 Check here if Amendment /_/; Amendment Number: _______ This Amendment (Check only one): /_/ is a restatement. /_/ adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Accipiter Capital Management, LLC Address: 399 Park Avenue, 38th Floor New York, New York 10022 Form 13F File Number: 28-10741 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Gabe Hoffman Title: Managing Member Phone: 212-705-8700 Signature, Place, and Date of Signing: /s/ Gabe Hoffman, New York, NY, May 15, 2008 Report Type (Check only one): /X/ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) /_/ 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) /_/ 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 1 --------------- Form 13F Information Table Entry Total: 47 --------------- Form 13F Information Table Value Total: $437,660 --------------- (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 28-11738 Gabe Hoffman ----- ----------------------- ----------------------- FORM 13F INFORMATION TABLE
VOTING AUTHORITY ---------------- TITLE OF VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER NAME OF ISSUER CLASS CUSIP (X$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- ----- ----- -------- ------- --- ---- ---------- -------- ---- ------ ---- ACCURAY INC COM 004397105 15,345 1,964,843 S/H OTHER 1 - 1,964,843 - ACURA PHARMACEUTICALS INC COM 00509L703 74 8,499 S/H OTHER 1 - 8,499 - NEW AMAG PHARMACEUTICALS INC COM 00163U106 21,503 531,865 S/H OTHER 1 - 531,865 - AMERICAN MED SYS HLDGS INC COM 02744M108 2,624 184,949 S/H OTHER 1 - 184,949 - ASPENBIO PHARMA INC COM 045346103 595 103,000 S/H OTHER 1 - 103,000 - ATHERSYS INC COM 04744L106 4,949 1,319,605 S/H OTHER 1 - 1,319,605 - ATS MED INC COM 002083103 7,135 5,060,421 S/H OTHER 1 - 5,060,421 - AVIGEN INC COM 053690103 2,719 974,429 S/H OTHER 1 - 974,429 - BIOMARIN PHARMACEUTICAL INC COM 09061G101 6,751 190,874 S/H OTHER 1 - 190,874 - COOPER COS INC COM 216648402 16,152 469,126 S/H OTHER 1 - 469,126 - NEW DIALYSIS CORP AMER COM 252529102 2,519 345,593 S/H OTHER 1 - 345,593 - DYAX CORP COM 26746E103 2,210 469,267 S/H OTHER 1 - 469,267 - EMAGEON INC COM 29076V109 5,843 2,562,704 S/H OTHER 1 - 2,562,704 - EV3 INC COM 26928A200 38,025 4,671,344 S/H OTHER 1 - 4,671,344 - GENTIUM S P A SPONSORED 37250B104 469 73,110 S/H OTHER 1 - 73,110 - ADR GTX INC DEL COM 40052B108 804 50,000 S/H OTHER 1 - 50,000 - HANSEN MEDICAL INC COM 411307101 2,680 190,600 S/H OTHER 1 - 190,600 - HEALTH MGMT ASSOC INC NEW CL A 421933102 30,012 5,673,377 S/H OTHER 1 - 5,673,377 - HEALTHSOUTH CORP COM 421924309 3,643 204,761 S/H OTHER 1 - 204,761 - NEW HI-TECH PHARMACAL INC COM 42840B101 6,549 723,639 S/H OTHER 1 - 723,639 - HYTHIAM INC COM 44919F104 242 200,000 S/H OTHER 1 - 200,000 - LIFEPOINT HOSPITALS INC COM 53219L109 16,270 592,271 S/H OTHER 1 - 592,271 - MEDICIS PHARMACEUTICAL CORP CL A 584690309 11,393 578,599 S/H OTHER 1 - 578,599 - NEW MEDIS TECHNOLOGIES LTD COM 58500P107 227 25,000 S/H OTHER 1 - 25,000 - MERCK & CO INC COM 589331107 190 5,000 S/H OTHER 1 - 5,000 - MERIT MED SYS INC COM 589889104 13,588 858,376 S/H OTHER 1 - 858,376 - MYLAN INC COM 628530107 29,636 2,554,800 S/H OTHER 1 - 2,554,800 - NIGHTHAWK RADIOLOGY HLDGS IN COM 65411N105 14,641 1,564,229 S/H OTHER 1 - 1,564,229 - NORTHSTAR NEUROSCIENCE INC COM 66704V101 2,736 1,731,644 S/H OTHER 1 - 1,731,644 - NOVACEA INC COM 66987B103 3,500 1,296,157 S/H OTHER 1 - 1,296,157 - OCULUS INNOVATIVE SCIENCES I COM 67575P108 127 25,000 S/H OTHER 1 - 25,000 - OMRIX BIOPHARMACEUTICALS INC COM 681989109 8,990 642,126 S/H OTHER 1 - 642,126 - ORCHID CELLMARK INC COM 68573C107 5,745 2,015,825 S/H OTHER 1 - 2,015,825 - OSIRIS THERAPEUTICS INC COM 68827R108 118 9,380 S/H OTHER 1 - 9,380 - PDL BIOPHARMA INC COM 69329Y104 21,178 1,999,779 S/H OTHER 1 - 1,999,779 - PENWEST PHARMACEUTICALS CO COM 709754105 3,162 1,216,086 S/H OTHER 1 - 1,216,086 - RURAL / METRO CORP COM 781748108 8,671 3,721,647 S/H OTHER 1 - 3,721,647 - SANGAMO BIOSCIENCES INC COM 800677106 84 8,300 S/H OTHER 1 - 8,300 - SCHERING PLOUGH CORP COM 806605101 16,718 1,160,200 S/H OTHER 1 - 1,160,200 - SIRTRIS PHARMACEUTICALS INC COM 82968A105 1,299 100,000 S/H OTHER 1 - 100,000 - ST JUDE MED INC COM 790849103 6,242 144,515 S/H OTHER 1 - 144,515 - TRIMERIS INC COM 896263100 11,477 1,760,311 S/H OTHER 1 - 1,760,311 - TRIPLE-S MGMT CORP CL B 896749108 49,983 2,831,925 S/H OTHER 1 - 2,831,925 - UNITED THERAPEUTICS CORP DEL COM 91307C102 14,643 168,888 S/H OTHER 1 - 168,888 - UNITEDHEALTH GROUP INC COM 91324P102 2,914 84,800 S/H OTHER 1 - 84,800 - WELLPOINT INC COM 94973V107 18,971 429,900 S/H OTHER 1 - 429,900 - YM BIOSCIENCES INC COM 984238105 4,314 4,449,375 S/H OTHER 1 - 4,449,375 -
-----END PRIVACY-ENHANCED MESSAGE-----